Adults with Down's sydrome: The prevalence of complications and health care in the community

British Journal of General Practice

Volumn 57, Issue 534, 2007, Pages 50-55

  Henderson, Alex ^a   Lynch, Sally A ^b   Wilkinson, Steve ^c   Hunter, Morag ^c  

^a INSTITUTE OF HUMAN GENETICS   (United Kingdom)

^b NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c TYNE AND WEAR NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Down's syndrome; Genetic screening; Health care surveys; Prevalence; Screening

Indexed keywords

ADULT; ALZHEIMER DISEASE; ARTICLE; CELIAC DISEASE; CHROMOSOME ANALYSIS; COMMUNITY CARE; COMORBIDITY; DEMENTIA; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DOWN SYNDROME; ECHOCARDIOGRAPHY; EYE DISEASE; FALLOT TETRALOGY; FEMALE; GENETIC SCREENING; HEALTH CARE ACCESS; HEALTH SURVEY; HEARING IMPAIRMENT; HEARING TEST; HEART SEPTUM DEFECT; HUMAN; HYPOTHYROIDISM; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBESITY; PATENT DUCTUS ARTERIOSUS; PERIODIC MEDICAL EXAMINATION; PREVALENCE; PRIMARY MEDICAL CARE; THYROID FUNCTION TEST; UNITED KINGDOM; VALVULAR HEART DISEASE;

ADOLESCENT; ADULT; COMMUNITY HEALTH SERVICES; DOWN SYNDROME; ENGLAND; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; PREVALENCE;

EID: 33846103510     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Marder E, Dennis J. Medical management of children with Down's Syndrome. Curr Paediatr 2001; 11: 57-63.
2. Bell R, Rankin J, Donaldson LJ, Northern Congenital Abnormality Survey Steering Group. Down's syndrome: occurrence and outcome in the north of England, 1985-99. Paediatr Perinat Epidemiol 2003; 17(1):33-39.
3. Van Allen MI, Fung J, Jurenka SB. Health care concerns and guidelines for adults with Down syndrome. Am J Med Genet 1999; 89(2): 100-110.
4. Cohen W. Health care guidelines for individuals with Down syndrome: 1999 revision. Down Syndrome Quarterly 1999; 4: 1-15.
5. American Academy of Pediatrics Committee on Genetics. Health supervision for children with Down syndrome. Paediatrics 2001; 107(2):442-449.
6. Noble SE, Leyland K, Findlay CA, et al. School based screening for hypothyroidism in Down's syndrome by dried blood spot TSH measurement. Arch Dis Child 2000; 82(1): 27-31.
7. Leonard S, Bower C, Petterson B, et al. Survival of infants born with Down's syndrome: 1980-96. Paediatr Perinat Epidemol 2000; 14(2): 163-171.
8. Yang Q, Rasmussen SA, Friedman JM. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet 2002; 359: 1019-1025.
9. Bittles AH, Glasson EJ. Clinical, social and ethical implications of changing life expectancy in Down syndrome. Dev Med Child Neurol 2004; 46(4): 282-286.
10. Baird AP, Sadovnick AD. Life expectancy in Down syndrome adults. Lancet 1988; 2: 1354-1356.
11. Steffelaar JW, Evenhuis HM. Life expectancy, Down syndrome, and dementia. Lancet 1989; 1: 492-493.
12. NHS Employers. Quality and Outcomes Framework guidance 2006/07. Revisions to the GMS contract 2006/07. http://www.nhsemployers.org/ primary/primary-886.cfm (accessed 7 Dec 2006).
13. American Academy of Pediatrics Committee on Genetics. Health supervision for children with Down syndrome. Paediatrics 2001; 107(2):442-449.
14. Pueschel S, Anneren G, Durlach R, Flores J, Sustrova M, Verma I. Guidelines for optimal medical care of persons with Down syndrome. International League of Societies for Persons with Mental Handicap (ILSMH). Acta Paediatr 1995; 84(7): 823-827.
15. Smith DS. Health care management of adults with Down syndrome. Am Fam Physician 2001; 64(6): 1031-1038.
16. Dennis J. Basic medical surveillance essentials for people with Down's syndrome. Cardiac disease: congenital and acquired. http://www.dsmig.org.uk/library/articles/guideline-cardiac-5.pdf (accessed 14 Nov 2006).
17. Goldhaber SZ, Brown WD, Sutton MG. High frequency of mitral valve prolapse and aortic regurgitation among asymptomatic adults with Down's syndrome. JAMA 1987; 258: 1793-1795.
18. Prasher V. Reliability of diagnosing hypothyroidism in adults with Down syndrome. J Intellect Dev Disabil 1995; 20(3): 223-233.
19. Selikowitz M. A five-year longitudinal study of thyroid function in children with Down syndrome. Dev Med Child Neurol 1993; 35(5): 396-401.
20. Schwartz DM, Schwartz RH. Acoustic impedance and otoscopic findings in young children with Down Syndrome. Arch Otolaryngol 1978; 104: 652-656.
21. DSMIG. Basic Surveillance essential for people with Down's Syndrome. Ophthalmic problems: key points. http://www.dsmig.org.uk/library/ articles/keypoints-vision.html (accessed 14 Nov 2006).
22. Dennis J, Charlton C, Holmes G. Down's syndrome coeliac disease/gluten sensitivity: a DSMIG Clinical Awareness Note. http://www.dsmig.org.uk/ library/articles/coeliac-awareness-notes.pdf (accessed 14 Nov 2006).
23. Rubin SS, Rimmer JH, Chicoine B, et al. Overweight prevalence in persons with Down syndrome. Ment Retard 1998; 36(3): 175-181.
24. Holland AJ, Hon J, Huppert FA, et al. Incidence and course of dementia in people with Down's syndrome: findings from a population-based study. J Intellect Disabil Res 2000; 44(Pt 2): 138-146.
25. Dennis J, Elliman D. Down's Syndrome: immunisation. http://www.dsmig.org.uk/library/articles/keypoints-immunisation.pdf (accessed 14 Nov 2006).
26. Steele J. Epidemiology: incidence, prevalence and size of the Down's syndrome population. In: Stratford B, Gunn P, (eds). New approaches to down syndrome. London: Cassell, 1996: 45-72.
27. Pueschel SM. Clinical aspects of Down syndrome from infancy to adulthood. Am J Med Genet Suppl 1990; 7: 52-56.
28. Baxter H, Lowe K, Houston H, et al. Previously unidentified morbidity in patients with intellectual disability. Br J Gen Pract 2006; 56: 93-98.
29. Book L, Hart A, Black J, et al. Prevalence and clinical characteristics of coeliac disease in Downs syndrome in a US study. Am J Med Genet 2001; 98(1): 70-74.